申请人:ELI LILLY AND COMPANY
公开号:EP0106487A2
公开(公告)日:1984-04-25
it has been found that novel bridged hexahydrobenz-[f]isoquinoline derivatives, or a pharmaceutically-acceptable salt thereof, are useful analgesic agents, having both narcotic agonist and antagonist properties, as well as psychotropic characteristics.
研究发现,新型桥接六氢苯并[f]异喹啉衍生物或其药学上可接受的盐是有用的镇痛剂,具有麻醉激动剂和拮抗剂特性以及精神作用特性。